These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9350417)

  • 1. Anti-Legionella activity of trovafloxacin compared with seven other antimicrobial agents including an intermethod evaluation.
    Marco F; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 1997 Sep; 29(1):55-7. PubMed ID: 9350417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: influence of charcoal on susceptibility test results.
    García MT; Pelaz C; Giménez MJ; Aguilar L
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2176-8. PubMed ID: 10898695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluations of the Etest for antimicrobial susceptibility testing of Legionella pneumophila, including validation of the imipenem and sparfloxacin strips.
    Rhomberg PR; Jones RN
    Diagn Microbiol Infect Dis; 1994 Nov; 20(3):159-62. PubMed ID: 7874883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
    Dubois J; St-Pierre C
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest results.
    Jones RN; Barrett MS; Deguchi T
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):193-200. PubMed ID: 9327248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
    Dubois J; St-Pierre C
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Ren J; Polzer R; Gladue RP
    Antimicrob Agents Chemother; 1996 Feb; 40(2):314-19. PubMed ID: 8834872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.
    Jones RN; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):119-26. PubMed ID: 9823536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.
    Gómez-Lus R; Adrián F; del Campo R; Gómez-Lus P; Sánchez S; García C; Rubio MC
    Int J Antimicrob Agents; 2001 Jul; 18(1):49-54. PubMed ID: 11463526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates.
    Gooding BB; Erwin ME; Barrett MS; Johnson DM; Jones RN
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2049-50. PubMed ID: 1329642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
    Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
    Stout JE; Sens K; Mietzner S; Obman A; Yu VL
    Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp.
    Croco MA; Biedenbach DJ; Pfaller MA; Doern GV; Jones RN
    J Antimicrob Chemother; 1998 Nov; 42(5):672-3. PubMed ID: 9848457
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis.
    Jones RN; Ballow CH; Schentag JJ; Johnson DM; Deinhart JA
    Diagn Microbiol Infect Dis; 1998 May; 31(1):313-25. PubMed ID: 9597392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections.
    Endtz HP; Mouton JW; den Hollander JG; van den Braak N; Verbrugh HA
    Antimicrob Agents Chemother; 1997 May; 41(5):1146-9. PubMed ID: 9145886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp.
    Dubois J; Joly JR
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):89S-91S. PubMed ID: 2791504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
    Pendland SL; Martin SJ; Chen C; Schreckenberger PC; Danziger LH
    J Clin Microbiol; 1997 Nov; 35(11):3004-6. PubMed ID: 9350781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia.
    Urbásková P; Trupl J; Hupková H; Appelbaum PC; Jacobs MR
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):686-8. PubMed ID: 8894582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
    Baltch AL; Smith RP; Ritz W
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.
    Visalli MA; Bajaksouzian S; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1475-81. PubMed ID: 9210669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.